Navigation Links
ASPEX Corporation is Shifting the Identity of SEMs
Date:3/2/2010

PITTSBURGH, March 2 /PRNewswire/ -- ASPEX Corporation (ASPEX) has been advancing the novel Personal Scanning Electron Microscope (PSEM) platform since its first product generation was released in 1992. Since then, it has been "shifting" where SEMs are traditionally installed, "shifting" when SEMs are utilized in industrial processes, and fundamentally "shifting" how SEMs are identified. Come experience the shift at Pittcon 2010, in Orlando, FL from March 1-4.

At Booth #507, ASPEX will display its game-changing PSEM eXpress™, a benchtop analyzer that is smaller and more cost-effective than traditional scanning electron microscopes. Since its debut, the PSEM eXpress™ has been solving real-world quality control issues in a variety of industries, including industrial automation, metals, health sciences, and forensics. Additionally, ASPEX will present a poster session highlighting the "Implementation of Next Generation Electron Beam Analyzer in Contamination Diagnostics" at the Blue Area, Hall A2, Aisles 700-1300 on Monday, March 1st, 2010.

"The PSEM eXpress™ represents several new advancements, from more functional product packaging, to one-click reporting," said Greg Ott, President of ASPEX. "Not only does the PSEM eXpress™ illustrate yet again another shifting of the identity of SEMs, but it represents ASPEX's response to the marketplace. Reliability, performance, and value are what we strive to deliver as product features. Based on market feedback, the PSEM eXpress™ has continued the brand in grand style."

ABOUT ASPEX: ASPEX is the leading provider of integrated microanalysis solutions for a wide range of critical cleanliness, microcontamination analysis, product purity, contamination diagnostics, predictive maintenance, and other process control initiatives incorporating scanning electron microscopes and elemental analysis technologies. The company's custom solutions are at work in a variety of application-specific tasks in the steel, forensics, pharmaceutical, and automotive industries. Its full-service headquarters are located in Pittsburgh, PA.

Additional information about ASPEX and its tools for particle size analysis is located at http://www.aspexcorp.com.

SOURCE ASPEX

Back to top

RELATED LINKS
http://www.aspexcorp.com

'/>"/>

SOURCE ASPEX
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ASPEX Kicks Off Free Send Us Your Sample Microscopy Campaign
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. CEL-SCI Corporation Releases Letter to Shareholders
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
7. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
8. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
11. Immunosyn Corporation Releases SF-1019 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it ... at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, ... health analytics to improve Medicaid population health management. , ODH will also have an ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert standing desk ... and advantages built into the home office sit stand solution are bold colors, ... to gain the benefits embedded in the TaskMate Go are available 24/7 through ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
Breaking Medicine News(10 mins):